QIAGEN to Provide State|of|the|Art Technologies and Platforms for ...

QIAGEN to Provide State-of-the-Art Technologies and Platforms for ...

QIAGEN to Provide State-of-the-Art Technologies and Platforms for Gene Mutation Analysis and Sample Preparation Automation. News. Published ...

Research & Technology - QIAGEN

Working in a field of life sciences? Allow us to guide you in understanding life's molecular building blocks, enabling you to gain new insights into the ...

Digital Tools & Platforms - QIAGEN

It is crucial for laboratories, research or clinical, to find a way to embrace digital solutions and gain efficiencies.

Our products - QIAGEN

Key product areas. QIAGEN's technologies provide versatile solutions for many research and diagnostic applications. Here you can find details of some of our ...

QIAGEN launches API to streamline access to world-leading ...

The QIAGEN Biomedical Knowledge Base (QIAGEN BKB) API will allow researchers to more easily use knowledge graphs, artificial intelligence (AI) and machine ...

QIAGEN expands QIAcuity digital PCR offering with over new 100 ...

100 new assays for its digital PCR (dPCR) platform QIAcuity for use in the study of cancer, inherited genetic disorders, infectious disease surveillance, and ...

ATCC Announces Expansion of its Bioinformatics Data ... - Virginia Bio

ATCC's collection of high-fidelity, authenticated DNA-seq and RNA-seq datasets to be included in QIAGEN's databases for biotechnology and ...

Applications & Insights - QIAGEN

... technologies, tools and services you need to help you on your journey. Research & TechnologyDiagnostic & ClinicalApplied & IndustrialDigital Tools & Platforms ...

ATCC Announces Expansion of its Bioinformatics Data Platform with ...

ATCC announced that it has entered into an agreement with QIAGEN, a recognized leader in bioinformatics solutions, to provide them with ...

Pyrosequencing Technology and Platform Overview - QIAGEN

Characterization of complex DNA modifications underlying gene expression patterns requires quantifiable sequence data. Pyrosequencing is a sequence-based ...

Qiagen Aims to Broadly Occupy Liquid Biopsy Space ... - GenomeWeb

Customers also have the option to use PCR-based solutions. Qiagen offers targeted panels for this workflow, as well as the PCR platforms to run ...

ATCC Announces Expansion of its Bioinformatics Data Platform with ...

ATCC announced that it has entered into an agreement with QIAGEN to provide them with sequencing data from its collection of cell lines.

QIAGEN: Sample to Insight

Join our webinar series on November 14 & 21 as we unbox the essential toolboxes that you will need for molecular PCR assay development. Join webinar · The right ...

Unlock the potential of (NGS) next-generation sequencing - QIAGEN

Discover QIAGEN next generation sequencing solutions for RNA-seq and DNA-seq to multimodal and epigenetic applications, supported by Genomic Services and ...

About QIAGEN

QIAGEN serves over 500000 customers around the globe with Sample to Insight solutions for molecular testing.

Evotec and QIAGEN enter software collaboration for enhanced multi ...

QIAGEN Digital Insights, the bioinformatics business of QIAGEN, is the leading provider ... technologies, data and science for the ...

QIAGEN launches QIAcuityDx digital PCR system for clinical testing ...

And that is something that other existing technologies are unable to offer,” she added. The QIAcuityDx platform is an IVD medical device ...

Historical Development - QIAGEN

... technologies; QIAGEN introduces the EZ2 Connect MDx platform, offering automated sample processing and standardized nucleic acid purification for diagnostic ...

QIAGEN N.V. - Drug Target Review

Assay technologies make these biomolecules visible and ready for analysis. ... QIAGEN provides solutions to more than 500,000 customers around the world in ...

Building a 21st Century Bioeconomy QIAGEN Response

Assay technologies are then used to make specific target biomolecules, such as the DNA of a specific virus, visible for subsequent analysis. We have developed ...